CAR T Cell Therapy: Engineering the Immune System to Fight Pediatric Cancer
Take a closer look at the role of T cells in cancer therapy and the development of chimeric antigen receptor (CAR) T cells. Explore the early successes and challenges in the development of CAR T cell therapy in pediatric leukemia. Presented by Dr. Amanda Li, Clinical Assistant Professor, Department of Pediatrics, UBC; Attending Physician, BC Children's Hospital. (2019)
Congratulations to the BC Children’s Hospital Research Institute (BCCHR) and Women’s Health Research Institute (WHRI) investigators and their teams who were awarded $11 million in funding through the Canadian Institutes of Health Research (CIHR) Fall 2023 Project Grant competition.
While growing up, Abisola Kehinde was fascinated by biology, one of those courses she didn’t have to study much to easily understand. It was natural to her, so choosing a career in science was a no-brainer. She was never told that, as a woman, there wasn’t space for her in this field. But there were other challenges related to gender biases.
Researchers made a key discovery about how childhood acute lymphoblastic leukemia (ALL) evolves and responds to targeted therapies suggesting that clinicians can start looking for precision treatments for a child’s cancer immediately after diagnosis, rather than waiting until the cancer has come back.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.